Drug intelligence / Profile preview

Huolisu

Development stage
Phase 4
Lead developer
Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital
Administration
Oral
01

Overview

Huolisu is a Traditional Chinese Medicine (TCM) formulation, primarily used as an oral solution to treat symptoms associated with kidney deficiency and blood insufficiency, such as insomnia, dizziness, fatigue, and forgetfulness. The formulation is a combination of several herbal extracts, including processed *Polygonum multiflorum* (He Shou Wu), *Epimedium* (Yin Yang Huo), *Polygonatum sibiricum* (Huang Jing), *Lycium barbarum* (Gou Qi Zi), *Astragalus membranaceus* (Huang Qi), and *Salvia miltiorrhiza* (Dan Shen). In clinical settings, it is being evaluated for its efficacy in managing depression in patients who have undergone percutaneous coronary intervention (PCI), with research focusing on its ability to regulate the hypothalamic-pituitary-target gland axis and address TCM syndromes of kidney Yang and Yin deficiency. It is manufactured by companies such as Sichuan Kelun Pharmaceutical.

Brand names
Huolisu
Other names
Huolisu oral solutionHuolisu Koufuye活力苏
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)GAPDH (Glyceraldehyde-3-phosphate dehydrogenase)JUN (Transcription factor Jun)TP53 (Cellular Tumor Antigen p53 R175H)

Beyond the preview

Go deeper on Huolisu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huolisu.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call